- Previous Close
0.0050 - Open
0.0000 - Bid --
- Ask 0.0050 x --
- Day's Range
0.0050 - 0.0050 - 52 Week Range
0.0050 - 0.0100 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
1.416M - Beta (5Y Monthly) 1.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0500 - Earnings Date Feb 26, 2025 - Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform. The company is headquartered in Toronto, Ontario.
braxiascientific.comRecent News: BRAX.CN
View MorePerformance Overview: BRAX.CN
Trailing total returns as of 2/7/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BRAX.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BRAX.CN
View MoreValuation Measures
Market Cap
1.42M
Enterprise Value
1.92M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.59
Price/Book (mrq)
--
Enterprise Value/Revenue
0.87
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-42.36%
Return on Equity (ttm)
-254.59%
Revenue (ttm)
2.21M
Net Income Avi to Common (ttm)
-9.64M
Diluted EPS (ttm)
-0.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
128.34k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-970.83k